Variant report
Variant | esv11882 |
---|---|
Chromosome Location | chr6:133745934-133747363 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:133746912..133749125-chr6:133760477..133762589,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000223542 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188592022 | chr6:133745953-133745954 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538678597 | chr6:133745954-133745955 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9493620 | chr6:133746011-133746012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542158481 | chr6:133746016-133746017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs57243011 | chr6:133746040-133746041 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs527503917 | chr6:133746069-133746070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149840822 | chr6:133746086-133746087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564112124 | chr6:133746121-133746122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35531766 | chr6:133746184-133746185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533513734 | chr6:133746238-133746239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563669986 | chr6:133746243-133746244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549997312 | chr6:133746246-133746247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145468604 | chr6:133746248-133746249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs193263709 | chr6:133746252-133746253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549285537 | chr6:133746253-133746254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs367634553 | chr6:133746275-133746276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185138468 | chr6:133746280-133746281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552312133 | chr6:133746301-133746302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148816155 | chr6:133746316-133746317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370632821 | chr6:133746404-133746405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142497557 | chr6:133746442-133746443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6917488 | chr6:133746497-133746498 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs1889946 | chr6:133746544-133746545 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs11374264 | chr6:133746575-133746576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9493621 | chr6:133746589-133746590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373656213 | chr6:133746601-133746602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575994586 | chr6:133746608-133746609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150462 | chr6:133746648-133746649 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs1889947 | chr6:133746650-133746651 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs189040103 | chr6:133746657-133746658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552061121 | chr6:133746670-133746671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181132846 | chr6:133746717-133746718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568885880 | chr6:133746724-133746725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116735103 | chr6:133746747-133746748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532942666 | chr6:133746752-133746753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550250544 | chr6:133746812-133746813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532055269 | chr6:133746842-133746843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563602893 | chr6:133746848-133746849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539389948 | chr6:133746880-133746881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs76390997 | chr6:133746888-133746889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548997458 | chr6:133746917-133746918 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs79774421 | chr6:133746938-133746939 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs375974265 | chr6:133746988-133746989 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs3777849 | chr6:133747025-133747026 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs571823595 | chr6:133747056-133747057 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs537204906 | chr6:133747078-133747079 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs556249374 | chr6:133747080-133747081 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs576022477 | chr6:133747089-133747090 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs114431344 | chr6:133747110-133747111 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs76054319 | chr6:133747111-133747112 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:133720200-133748400 | Weak transcription | Hela-S3 | cervix |
2 | chr6:133720400-133749600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr6:133726600-133752200 | Weak transcription | Right Atrium | heart |
4 | chr6:133732600-133758200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr6:133736400-133752200 | Weak transcription | Fetal Muscle Leg | muscle |
6 | chr6:133737400-133746800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
7 | chr6:133744000-133748000 | Enhancers | Liver | Liver |
8 | chr6:133744400-133752400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
9 | chr6:133745000-133746200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr6:133745200-133746000 | Enhancers | Gastric | stomach |
11 | chr6:133745200-133746000 | Enhancers | Pancreas | Pancrea |
12 | chr6:133745400-133746000 | Enhancers | Psoas Muscle | Psoas |
13 | chr6:133745400-133747400 | Weak transcription | Right Ventricle | heart |
14 | chr6:133745600-133746000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
15 | chr6:133745800-133748000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
16 | chr6:133746000-133747000 | Weak transcription | Psoas Muscle | Psoas |
17 | chr6:133746000-133747200 | Weak transcription | Gastric | stomach |
18 | chr6:133746000-133753200 | Weak transcription | Fetal Muscle Trunk | muscle |
19 | chr6:133746800-133748200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
20 | chr6:133747000-133748000 | Enhancers | Psoas Muscle | Psoas |
21 | chr6:133747200-133747400 | Enhancers | Gastric | stomach |